v3.26.1
Revenues
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenues

Note 2. Revenues

Disaggregation of Revenue

The following table depicts the Company's disaggregated revenue for the periods presented:

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Subscription

 

$

19,053

 

 

$

25,232

 

Advisory

 

 

329

 

 

 

1,063

 

Advertising

 

 

254

 

 

 

455

 

Other revenue

 

 

389

 

 

 

761

 

Total

 

$

20,025

 

 

$

27,511

 

Revenue by Geographic Locations

The following table depicts the Company’s revenue by geographic operations for the periods presented:

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

North America

 

$

18,775

 

 

$

21,910

 

Rest of the world

 

 

1,250

 

 

 

5,601

 

Total

 

$

20,025

 

 

$

27,511

 

Revenues by geography are determined based on the region of the Company's contracting entity, which may be different than the region of the customer. North America revenue consists solely of revenue attributed to the United States. For the three months ended March 31, 2026 and 2025, revenue attributed to Belgium (presented within the Rest of the world in the above table) represented approximately 6% and 4% of total revenues, respectively. For the three months ended March 31, 2025, revenue attributed to the United Kingdom (presented within the Rest of the world in the above table) represented approximately 15% of total revenues. No other foreign country represented more than 5% of total revenue during the three months ended March 31, 2026 and 2025.

Contract Assets

The Company had contract assets of $244, $590, and $1,240 as of March 31, 2026, December 31, 2025, and December 31, 2024, respectively. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collections. They represent a conditional right to consideration for satisfied performance obligations that becomes a receivable when the conditions are satisfied. They are recorded as part of other current assets on the condensed consolidated balance sheets.

Deferred Revenue

Details of the Company’s deferred revenue for the periods presented are as follows:

Balance at December 31, 2024

 

$

35,475

 

Sale of Dragonfly and Oxford Analytica

 

 

(7,342

)

Revenue recognized in the current period from amounts in the prior balance

 

 

(17,472

)

New deferrals, net of amounts recognized in the current period

 

 

25,621

 

Effects of foreign currency

 

 

277

 

Balance at March 31, 2025

 

$

36,559

 

 

 

 

 

Balance at December 31, 2025

 

$

30,044

 

Revenue recognized in the current period from amounts in the prior balance

 

 

(13,408

)

New deferrals, net of amounts recognized in the current period

 

 

18,142

 

Effects of foreign currency

 

 

(54

)

Balance at March 31, 2026

 

$

34,724

 

Costs to Obtain

During the three months ended March 31, 2026 and 2025, the Company capitalized $301 and $524 of costs to obtain revenue contracts. The Company amortized costs capitalized to obtain revenue contracts in the amount of $694 and $884 to sales and marketing expense during the three months ended March 31, 2026 and 2025, respectively. There were no impairments of costs capitalized to obtain revenue contracts for the three months ended March 31, 2026 and 2025.

Unsatisfied Performance Obligations

At March 31, 2026, the Company had $68,684 of remaining contract consideration for which revenue has not been recognized due to unsatisfied performance obligations. The Company expects to recognize this over the next five years.